Group 1 - The core point of the news is that Jiuzhoutong (SH 600998) announced significant share pledges by its major shareholders, which may impact the company's financial stability and investor confidence [1] - As of November 13, Jiuzhoutong's shareholder Shanghai Hongkang holds approximately 1.088 billion shares, accounting for 21.58% of the total share capital. After the recent pledge, Shanghai Hongkang has pledged about 633 million shares, representing 58.12% of its holdings and 12.54% of the total share capital [1] - The controlling shareholder, Chuchang Investment, along with its concerted parties, holds around 2.291 billion shares, which is 45.43% of the total share capital. Following the pledge, the total number of pledged shares by Chuchang Investment and its concerted parties is approximately 1.243 billion shares, accounting for 54.27% of their holdings and 24.66% of the total share capital [1] Group 2 - For the first half of 2025, Jiuzhoutong's revenue composition shows that pharmaceutical wholesale and related businesses account for 95.94%, pharmaceutical manufacturing for 1.96%, pharmaceutical retail for 1.84%, healthcare and technology services for 0.17%, and other businesses for 0.08% [1] - As of the report date, Jiuzhoutong's market capitalization is 26.2 billion yuan [2]
九州通:本次股份质押办理完成后,上海弘康累计质押公司股份约6.33亿股